Earnings Outlook For Bio-Techne
Portfolio Pulse from Benzinga Insights
Bio-Techne (NASDAQ:TECH) is expected to release its quarterly earnings report on February 1, 2024, with an estimated EPS of $0.41. Investors are looking for an earnings beat and positive guidance for future growth. The company's stock performance has been negative over the past year, with a 10.07% decline. Previous quarters show a pattern of the stock price dropping following earnings reports that did not meet estimates.
January 31, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bio-Techne is anticipated to report quarterly earnings with an estimated EPS of $0.41. Historical data shows stock price declines following earnings misses. Investors are focused on earnings performance and future guidance.
Bio-Techne's stock price has historically been sensitive to earnings reports, particularly when the company misses EPS estimates. The upcoming earnings report is crucial as it may either continue the trend of negative stock performance or reverse it if the company beats estimates and provides strong future guidance. However, given the mixed past performance and the overall negative trend in the stock price, the short-term impact is uncertain, hence a neutral score.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100